Federal Judge Sends Bayer Roundup $7.25 Billion Settlement Back to State Court

A federal judge rejected efforts by a group of objecting Roundup plaintiffs to permanently move Bayer's proposed $7.25 billion settlement from Missouri state court to federal court, returning the case to state court on June 17, 2026. The ruling is a setback for the objectors, who had sought to block or reshape the settlement through federal proceedings.

U.S. District Judge Henry Edward Autrey, in St. Louis, concluded that the objecting plaintiffs did not have the authority to remove the case to federal court because, under federal removal rules, only a defendant can do so. A final approval hearing before a Missouri state court judge remains scheduled for July 9, 2026.

The settlement and who opposes it

Bayer's subsidiary Monsanto proposed the $7.25 billion settlement in February 2026 to resolve current and future claims from people who allege they developed non-Hodgkin lymphoma after using Roundup, the widely sold glyphosate-based herbicide. 411 Press covered the filing when Bayer submitted it — see Bayer files $7.25 billion nationwide Roundup settlement. The opt-out deadline for claimants passed on June 4, 2026.

Roughly 65,000 Roundup lawsuits remain pending as of this report.

The objectors call the settlement collusive. They say it was not the product of genuinely adversarial litigation but a coordinated arrangement designed to manage Monsanto's liability while limiting the rights of cancer victims. They argue that some claimants would receive $10,000 or less, that the opt-out process was overly complex and difficult to complete, and that the structure resolving future claims is improper. To get before a federal judge, the objectors removed the case to federal court on the theory that they were the "true defendants" in the dispute, the argument Judge Autrey rejected.

Bayer's position

Bayer has argued that claimants are better served by accepting the settlement than waiting for court outcomes that may yield less. The company has pointed to a pending U.S. Supreme Court ruling that could affect failure-to-warn claims, a central theory in Roundup litigation. Given that uncertainty, Bayer says a settlement at this level is in claimants' best interest.

The Supreme Court's ruling has not yet been issued as of the date of this report.

What the June 17 ruling means

The federal court ruling removes one path the objectors were pursuing to delay or derail the settlement approval process. With the case back in Missouri state court, the July 9 final approval hearing moves forward under the state court's jurisdiction.

If the settlement receives final approval, the $7.25 billion fund would be distributed to participating claimants. The exact payout per claimant depends on the total number of valid claims, the severity and documentation of each person's illness, and the terms of the allocation plan.

Background: the Roundup litigation

Monsanto's Roundup is the best-selling herbicide in U.S. history and has been used on agricultural land, lawns, and right-of-ways for decades. Glyphosate, its active ingredient, was classified as "probably carcinogenic to humans" by the International Agency for Research on Cancer (IARC) in 2015, a classification Bayer and other researchers dispute.

Bayer acquired Monsanto in 2018 for approximately $63 billion and inherited the Roundup litigation. The company has paid out billions in prior verdicts and settlements — including a $2.1 billion Georgia jury verdict for a single plaintiff with non-Hodgkin lymphoma — and has been seeking a global resolution of the claims through a class settlement structure.

411 Press will update this story following the July 9 hearing.